Prognostic value and potential function of a novel heme-related LncRNAs signature in gastric cancer

被引:0
|
作者
Ma, Shuo [1 ]
Liao, Wei [2 ]
Chen, Yinhao [3 ]
Gan, Lin [4 ]
机构
[1] Southeast Univ, Sch Med, Nanjing 210009, Jiangsu, Peoples R China
[2] Chongqing Univ, Fuling Hosp, Dept Surg & Anesthesia, Chongqing 408000, Peoples R China
[3] Univ Hosp Bonn, Ctr Integrated Oncol CIO, Dept Integrated Oncol, D-53127 Bonn, Germany
[4] Chongqing Univ, Fuling Hosp, Dept Gen Surg, Chongqing 408000, Peoples R China
关键词
Gastric cancer; Long non-coding RNA; Heme metabolism; Immune infiltration; Immunotherapy; COLON-CANCER; HYPERPROLIFERATION; CYTOTOXICITY; ANGIOGENESIS; ACCUMULATION; INHIBITORS; CELLS; MEAT;
D O I
10.1016/j.cellsig.2024.111152
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Heme is a coordination complex formed by the binding of iron ions and porphyrin rings. Its metabolic processes are associated with various cancers, including gastric cancer (GC). In recent years, long non-coding RNAs (LncRNAs) have been identified as key regulatory factors in GC. However, the role of LncRNAs associated with heme metabolism in GC and their relationship with prognosis have not been reported. In this study, we constructed a novel LncRNAs signature related to heme metabolism (HMlncSig) and validated its prognostic value for predicting the survival of GC patients through training, test, and entire cohorts. Kaplan-Meier analysis demonstrated that patients in the high-risk group had shorter survival times. Univariate and multivariate Cox regression analysis showed that HMlncSig was an independent prognostic indicator for GC patients, regardless of other clinical pathological features. Gene ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analysis and gene set variation analysis pathways showed that the activation of these markers may be involved in tumor progression, influencing the survival of GC patients. The nomogram, based on HMlncSig score and clinical features, demonstrated the strong predictive ability of this signature. Additionally, significant differences were observed between the high-risk and low-risk groups in terms of immune cell subtypes, expression of immune checkpoint genes, and response to chemotherapy and immunotherapy. Through clinical validation, we found that the risk score and heme levels of GC patients were both significantly elevated and correlated with the degree of malignancy. Furthermore, we found that AP000692.1, a key gene in this signature, promoted the proliferation, migration, and invasion of GC cells. In conclusion, our HMlncSig model has significant predictive value for the prognosis of GC patients and can provide clinical guidance for personalized immunotherapy.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] A novel prognostic signature for lung adenocarcinoma based on cuproptosis-related lncRNAs: A Review
    Di, Huang
    Zhao, Jiting
    Zhu, Xue
    Zhou, Xinpeng
    Hu, Yuanlong
    Wang, Mengjie
    Qiu, Zhanjun
    Zhang, Wei
    Chen, Xianhai
    MEDICINE, 2022, 101 (49) : E31924
  • [32] Integrated analysis of a ceRNA network reveals potential prognostic lncRNAs in gastric cancer
    Qi, Mingran
    Yu, Bingxin
    Yu, Huiyuan
    Li, Fan
    CANCER MEDICINE, 2020, 9 (05): : 1798 - 1817
  • [33] Role of an Exosomes-Related lncRNAs Signature in Tumor Immune Microenvironment of Gastric Cancer
    Li, Chan
    Zhang, Zeyu
    Peng, Emin
    Peng, Jinwu
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [34] A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Therapeutic Response of Gastric Cancer
    Xiao, Shilang
    Liu, Xiaoming
    Yuan, Lingzhi
    Wang, Fen
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [35] Identification of a MAPK signaling-related lncRNAs signature and molecular subtypes of gastric cancer
    Chen, Di
    Zhu, Mengpei
    Huang, Yumei
    Xiong, Zhifan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 48 - 48
  • [36] Identification of a MAPK signaling-related lncRNAs signature and molecular subtypes of gastric cancer
    Chen, Di
    Zhu, Mengpei
    Huang, Yumei
    Xiong, Zhifan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 48 - 48
  • [37] A novel pyroptosis-related prognostic lncRNAs signature, tumor immune microenvironment and the associated regulation axes in bladder cancer
    Mo, Xiaocong
    Hu, Di
    Li, Yin
    Nai, Aitao
    Ma, Feng
    Bashir, Shoaib
    Jia, Guoxia
    Xu, Meng
    FRONTIERS IN GENETICS, 2022, 13
  • [38] Prognostic value and potential biological functions of ferroptosis-related gene signature in bladder cancer
    Wang, Yutong
    Shao, Wenchuan
    Feng, Yeqi
    Tang, Junzhe
    Wang, Qinchun
    Zhang, Dong
    Huang, Huaxing
    Jiang, Minjun
    ONCOLOGY LETTERS, 2022, 24 (03)
  • [39] Development and Experimental Validation of a Novel Prognostic Signature for Gastric Cancer
    Liu, Chengcheng
    Huo, Yuying
    Zhang, Yansong
    Yin, Fumei
    Chen, Taoyu
    Wang, Zhenyi
    Gao, Juntao
    Jin, Peng
    Li, Xiangyu
    Shi, Minglei
    Zhang, Michael Q.
    CANCERS, 2023, 15 (05)
  • [40] A novel cuproptosis-related lncRNAs signature predicts prognosis in bladder cancer
    Wu, Lingfeng
    Chen, Wei
    Cao, Yifang
    Chen, Bin
    He, Yi
    Wang, Xueping
    AGING-US, 2023, 15 (13): : 6445 - 6466